Robot arm takes the pain out of carpal tunnel injections?
NCT ID NCT07334964
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study tests whether using a robotic arm to guide injections for carpal tunnel syndrome is better than the standard manual method. Twenty adults with moderate to severe carpal tunnel syndrome will receive a corticosteroid injection either by robot or by hand. The goal is to see if the robot reduces pain and improves accuracy, potentially making the procedure easier for doctors and patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
21 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 and ≤ 75 years. 2. Clinical diagnosis of carpal tunnel syndrome. 3. Indication for corticosteroid injection as determined by investigator. 4. Moderate to severe carpal tunnel syndrome defined by a pain score on the Visual Analogue Scale (VAS) ≥ 4 (at baseline and on day 0). 5. Signed informed consent. Exclusion Criteria: 1. Known allergy to corticosteroids or povidone-iodine (Betadine) 2. Probable or ongoing systemic or local infection 3. History of injection in the affected wrist within the last 6 months 4. Thenar eminence atrophy 5. Trauma requiring surgery or immobilization 6. History of carpal tunnel surgery 7. Protected person (under guardianship or curatorship) 8. Person under judicial protection 9. Person deprived of liberty 10. Person not affiliated with a social security scheme 11. Pregnant or breastfeeding woman 12. Person participating in a drug trial
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Orléans
Orléans, 45067, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does mixing numbing agent into steroid shots ease hand pain?
- Blood protein may reveal how severe carpal tunnel syndrome is
- A carpal tunnel clue to a silent heart threat?
- Taping technique may offer Drug-Free relief for wrist pain
- One size Doesn't fit all: could pain 'Phenotypes' unlock better carpal tunnel care?
- Ultrasound may reveal hidden clues in carpal tunnel syndrome